PolarityTE Total Shareholders Equity 2011-2026 | PTE

Annual Total Shareholders Equity PolarityTE

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
16.6 M	19.2 M	27.3 M	38.9 M	72 M	170 K	5.4 M	15.7 M	5.55 M	20.1 M	29.3 M	23.2 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
72 M	170 K	22.8 M

Quarterly Total Shareholders Equity PolarityTE

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
12.4 M	16.6 M	16.9 M	20 M	17.8 M	19.2 M	26.9 M	26.8 M	28.3 M	27.3 M	27.3 M	27.3 M	27.3 M	38.9 M	38.9 M	38.9 M	38.9 M	72 M	72 M	72 M	72 M	-3.41 M	170 K	170 K	170 K	5.69 M	5.4 M	5.4 M	5.4 M	4.93 M	15.7 M	15.7 M	15.7 M	16 M	5.55 M	5.55 M	5.55 M	27.4 M	20.1 M	20.1 M	20.1 M	31.4 M	29.3 M	29.3 M	29.3 M	-	23.2 M	23.2 M	23.2 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
72 M	-3.41 M	23.3 M

Total Shareholders Equity of other stocks in the Biotechnology industry

Issuer	Total Shareholders Equity	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	621 M	-	2.43 %	$ 254 M	Germany
AbCellera Biologics ABCL	967 M	$ 3.55	-0.42 %	$ 1.06 B	Canada
Acorda Therapeutics ACOR	-158 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	66.6 M	-	4.01 %	$ 150 M	Canada
Advaxis ADXS	-24.4 M	-	-9.65 %	$ 45.9 M	USA
AC Immune SA ACIU	215 M	$ 3.25	3.83 %	$ 229 M	Schweiz
I-Mab IMAB	1.72 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	715 M	-	-	$ 1.01 B	USA
AgeX Therapeutics AGE	5.47 M	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	2.27 M	-	-13.47 %	$ 169 M	France
Albireo Pharma ALBO	176 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	54.4 M	-	10.36 %	$ 9.8 M	USA
Aptorum Group Limited APM	21.1 M	$ 0.79	0.04 %	$ 4.31 M	China
ADC Therapeutics SA ADCT	166 M	$ 4.12	-1.9 %	$ 105 M	Schweiz
Arcturus Therapeutics Holdings ARCT	214 M	$ 6.52	-1.66 %	$ 179 M	Israel
Midatech Pharma plc MTP	6.72 M	-	-18.52 %	$ 27.3 M	Britain
Adverum Biotechnologies ADVM	70.7 M	-	-	$ 86.2 M	USA
Ascendis Pharma A/S ASND	884 M	$ 229.5	-0.66 %	$ 5 B	Danmark
Applied Genetic Technologies Corporation AGTC	29.5 M	-	-	$ 26.5 M	USA
Alterity Therapeutics Limited ATHE	35.5 M	$ 3.43	-4.99 %	$ 8.25 B	Australia
Applied Molecular Transport AMTI	60.8 M	-	-	$ 10.1 M	USA
Atea Pharmaceuticals AVIR	275 M	$ 6.08	0.41 %	$ 495 M	USA
Akero Therapeutics AKRO	750 M	-	-	$ 3.67 B	USA
Athersys ATHX	16.4 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	234 M	-	0.23 %	$ 488 M	USA
Acer Therapeutics ACER	-16.8 M	-	2.71 %	$ 14 M	USA
ARCA biopharma ABIO	382 M	-	1052.0 %	$ 415 M	USA
Allena Pharmaceuticals ALNA	18.9 M	-	3.16 %	$ 1.9 M	USA
AlloVir ALVR	113 M	-	4.14 %	$ 49.1 M	USA
Anika Therapeutics ANIK	212 M	$ 14.54	1.25 %	$ 213 M	USA
Aptinyx APTX	38.3 M	-	-39.0 %	$ 4.57 M	USA
BioCardia BCDA	-1.6 M	$ 1.3	2.36 %	$ 27.5 M	USA
Aptose Biosciences APTO	-4.54 M	-	-45.71 %	$ 1.2 M	Canada
AVEO Pharmaceuticals AVEO	45.9 M	-	-	$ 521 M	USA
Ayala Pharmaceuticals AYLA	-1.1 M	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	19 M	$ 2.59	-1.79 %	$ 16.3 M	USA
Avenue Therapeutics ATXI	2.8 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	427 M	$ 1.51	-0.33 %	$ 385 M	Britain
Athira Pharma ATHA	44.8 M	-	-	$ 269 M	USA
BioNTech SE BNTX	1.37 B	$ 94.8	4.71 %	$ 27.2 B	Germany
CureVac N.V. CVAC	688 M	-	-	$ 867 M	Germany
Aravive ARAV	10.7 M	-	-13.39 %	$ 1.45 M	USA
Burford Capital Limited BUR	1.7 B	$ 8.29	2.79 %	$ 1.34 B	Britain
AstraZeneca PLC AZN	15.6 B	-	-	$ 96.9 B	Britain
Actinium Pharmaceuticals ATNM	32.8 M	$ 1.15	3.6 %	$ 34.6 M	USA